openPR Logo
Press release

Alzheimer Disease Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2021

01-16-2019 02:10 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: MarketReportsOnline

Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently available in the market have reached maturity; patent of leading drugs have expired. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies.

Access Full Report @ http://www.marketreportsonline.com/608756.html.

Global Alzheimer’s Disease Drugs Market and Pipeline Drugs Analysis

In 2016, the global market for Alzheimer’s disease drugs was dominated by Namenda, Memary, Aricept and Exelon. The combined market share of these four drugs was over 80% in the year 2016.

Ebixa, Razadyne/Reminyl, Rivastach and Nootropil are the other popular drugs in the Alzheimer’s disease market.

With the patent expiration of popular drugs the sales of the Alzheimer’s drugs have also declined. However, there are several pipeline drugs like Gantenerumab, Crenezumab and Aducanumab among others which are likely to hit the market during the period 2019 - 2020.

Global Alzheimer’s Disease Country Wise Analysis:

In the Alzheimer’s disease drugs market, the United States is the largest market.

Japan is the second leading market for Alzheimer’s disease drugs market accounting for XXX% market share in 2016.

China stands at the third spot in the global Alzheimer’s disease drugs market being followed by India with XXX% share in the same year.

The EU5 countries together accounted for over 10% share of the global Alzheimer’s disease drugs market in 2016.

Purchase a copy of this research report @ http://www.marketreportsonline.com/contacts/purchase.php?name=608756.

This research report titled “Global Alzheimer’s Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021” is a 189 Page report with 74 Figures and 14 Tables. This report provides a comprehensive assessment of the Alzheimer’s Disease Drugs Market, Alzheimer’s Disease Pipeline Drugs Market and Clinical Trials Analysis, Alzheimer’s Disease - Country Wise Drugs Market, Country Wise Alzheimer’s Disease Prevalence, Major Deals in Alzheimer’s Disease Drugs Market Landscape, Funding in Alzheimer’s Disease Drugs Research, Driving Factors and Challenges for Alzheimer’s Disease Drugs Market.

The 3 Pipeline Alzheimer’s Disease Drugs covered in the report are as follows:
1. Gantenerumab
2. Crenezumab
3. Aducanumab

The Alzheimer’s Disease Drugs Major Deals covered in the report are as follows:
1. Strategic Alliance
2. Licensing Agreement
3. Collaboration Deals
4. Mergers and Acquisitions

Browse all latest pharmaceuticals market research reports @ http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About Us:
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Contact Us:
Vishal Kalra
Tel: + 1 888 391 5441
Email: sales@marketreportsonline.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer Disease Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Forecast to 2021 here

News-ID: 1504101 • Views: 300

More Releases from MarketReportsOnline

Global Cloud Kitchen Market Size, Key Players, Covid-19 Impact Analysis, Growth …
“Global Cloud Kitchen Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in-depth analysis of the global cloud kitchen market by value, by kitchen type, by delivery type, by region, etc. The report provides a regional analysis of the global cloud kitchen market, including the following regions: North America (the US & Canada), Europe (UK, Germany, France, Italy, Spain & Rest of Europe), Asia (China, Japan, India,
The United States Toys Market is set to surpass US$ 56 Billion by 2027
• The Market Size of the United States Toys Market with Six Years Forecast • The United States Toys Market Share & Y-o-Y Growth (%), 2017 – 2027 • An Insightful Analysis of the United States Toys Market Segmentation and Forecast (2017 – 2027) • Tracks Competitive Developments, Approaches, Recent Industry Developments, Collaboration, Partnership Deals, and Licensing Agreement • Delivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the United States
The Maldives Tourism Market Emerging as a Dream Vacation Destination for the Int …
Maldives will attract more than 2.5 million international tourists and generated more than US$ 5 billion revenues by 2027. “Maldives Tourism Market” offers the most up-to-date industry data on the actual market situation and future outlook for Maldives tourism market. The report uses data and analysis to discuss future trends related to international tourists’ arrivals, spending, the purpose of visits and main destination markets. The report provides clear insight into current
The US Real Estate Appraisal Market with Covid-19 Impact, Size, Share, Key Playe …
"The US Real Estate Appraisal Market: Size and Forecasts with Impact Analysis of Covid-19 (2021-2025 Edition)" report provides an in-depth analysis of the US appraisal market by a number of licenses held, a number of active appraisers, by primary occupation, by value, etc. The sudden outbreak of the covid -19 pandemic has affected many industries around the globe. The impact of the pandemic on the US real estate appraisal market

All 5 Releases


More Releases for Alzheimer

Anti-β-Alzheimer Therapies Market Analysis with Technological Advancement and G …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as
Personal GPS Tracker to Keep Care of Suffering Alzheimer Patients
A GPS tracker is appropriate for Letstrak who are worried about keeping track of their loved ones. Many Alzheimer’s patients can get lost accidentally as they have trouble remembering why they left home and where they are going. By using a tracker, Letstrak can keep track of elderly patients without needing to be by their side 24 hours per day. The device is easy to secure on the wrist and